Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Aeterna Zentaris, Inc. (AEZS) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Aeterna Zentaris is an oncology and endocrinology drug development company that is presently investigating treatments for a variety of unmet medical needs. The company’s product pipeline consists of compounds at all stages of development – from drug discovery to marketed products. The company’s lead drug development candidates include Perifosine, AEZS-108 and AEZS-130. For more information, visit the company’s Web site: http://www.aezsinc.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *